Cangrelor
Cat. No.：YN322750
| 产品名称: | Cangrelor |
| CAS No.: | 163706-06-7 |
| Chemical Name: | N-[2-(Methylthio)ethyl]-2-[(3,3,3-trifluoropropyl)thio]-5'-adenylic Acid Monoanhydride with (Dichloromethylene)bis[phosphonic acid]; AR-C 69931; Kengreal |
| Synonyms: | Cangrelor,ARC69931,ARC 69931,ARC69931,ARC 69931 |
| 分子量: | 776.362 |
| 分子式: | C17H25Cl2F3N5O12P3S2 |
| SMILES: | CSCCNC1=NC(=NC2=C1N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O)O)SCCC(F)(F)F |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | Cangrelor (AR-C69931MX) 是一种三磷酸腺苷类似物，是一种静脉注射的、可逆的且具有选择性的血小板P2Y12拮抗剂，具有迅速有效的抗血小板作用。Cangrelor 直接阻断腺苷二磷酸 (ADP) 诱导的血小板活化和聚集。Cangrelor 也是一种非特异性的GPR17拮抗剂。 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Harrington, R., et al.: New England J. Med., 361, 2318 (2009)
van Giezen, J., et al.: Seminars in Thrombosis and Hemostasis, 31, 195 (2005)
